Recruiting Spinal Muscular Atrophy Studies in Memphis
About Spinal Muscular Atrophy Clinical Trials in Memphis
Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder that causes loss of motor neurons, leading to progressive muscle weakness and atrophy. It is the leading genetic cause of infant death. Revolutionary gene therapies and SMN-enhancing drugs have transformed treatment.
There are currently 6 spinal muscular atrophy clinical trials recruiting participants in Memphis, TN. These studies are seeking a combined 736 participants. Research is being sponsored by H. Lee Moffitt Cancer Center and Research Institute, Merck Sharp & Dohme LLC, Amgen and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Spinal Muscular Atrophy Clinical Trials in Memphis — FAQ
Are there spinal muscular atrophy clinical trials in Memphis?
Yes, there are 6 spinal muscular atrophy clinical trials currently recruiting in Memphis, TN. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Memphis?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Memphis research site will contact you about next steps.
Are clinical trials in Memphis free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Memphis studies also compensate for your time and travel.
What spinal muscular atrophy treatments are being tested?
The 6 active trials in Memphis are testing new therapies including novel drugs, biologics, and treatment approaches for spinal muscular atrophy.
Data updated July 19, 2026 from ClinicalTrials.gov